Human Genetic EngineeringThe first gene therapy trials on humans began in 1990 on patients with Severe Combined Immunodeficiency (SCID). In 2000, the first gene therapy "success" resulted in SCID patients with a functional immune system. These trials were stopped when it was discovered that two of ten patients in one trial had developed leukemia resulting from the insertion of the gene-carrying